Anti-Trypanosomal Bufadienolides from the Oocytes of the Toad Rhinella alata (Anura, Bufonidae)
Molecules · 2023
DOI: 10.3390/molecules29010196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Candelario Rodriguez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Biodiversidad y Descubrimiento de Drogas, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panamá 0…. Hauptthemen laut MEDLINE: Trypanosoma cruzi, Bufanolides, Chagas Disease. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría Nacional de Ciencia, Tecnología e Innovación, INDICASAT-BID Program.
Abstract (Originalsprache)
Amphibians are widely known as a prolific source of bioactive metabolites. In this work, we isolated and characterized compounds with antiparasitic activity from the oocytes of the toad Rhinella alata collected in Panama. Bio-guided isolation and structural elucidation were carried out using chromatographic and spectroscopic techniques, respectively. The organic extract was subjected to solid phase extraction followed by HPLC purification of the fraction with in vitro activity against Trypanosoma cruzi trypomastigotes. Seven steroids (1–7) of the bufadienolide family were isolated, and their structures were determined using NMR and MS analyses; of these 19-formyl-dyscinobufotalin, (3) is reported as a new natural product. Compounds 1 and 3–7 resulted in a good anti-trypanosomal activity profile. Among these, 16β-hydroxyl-hellebrigenin (1) and bufalin (7) showed significant selectivity values of >5 and 2.69, respectively, while the positive control benznidazole showed a selectivity of 18.81. Furthermore, molecular docking analysis showed compounds 1, 3 and 7 interact through H-bonds with the amino acid residues GLN-19, ASP-158, HIS-159 and TRP-177 from cruzipain at the catalytic site. Given the lack of therapeutic options to treat American trypanosomiasis, this work can serve as the basis for further studies that aim for the development of bufadienolides or their derivatives as drugs against Chagas disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centro de Biodiversidad y Descubrimiento de Drogas, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT-AIP), Panamá 0843-01103, Panama.
- Department of Biotechnology, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur 522510, India.
- Smithsonian Tropical Research Institute, Balboa, Ancon 0843-03092, Panama.
- Departamento de Zoología, Facultad de Ciencias Naturales, Exactas y Tecnología, Universidad de Panamá, Panamá 0824-03366, Panama.
- Centro de Investigaciones Farmacognósticas de la Flora Panameña (CIFLORPAN), Facultad de Farmacia, Universidad de Panamá, Panamá 0824-03366, Panama.
- Centro de Biología Celular y Molecular de Enfermedades, INDICASAT AIP, Panamá 0843-01103, Panama.
ORCID-Profile: Roberto Ibáñez, Dionisio A Olmedo, Carmenza Spadafora, Marcelino Gutiérrez
Förderung
- Secretaría Nacional de Ciencia, Tecnología e Innovación
- INDICASAT-BID Program
Zitieren
APA
Rodriguez, C., Ibáñez, R., Olmedo, D. A., Ng, M., Spadafora, C., Durant-Archibold, A. A., & Gutiérrez, M. (2023). Anti-Trypanosomal Bufadienolides from the Oocytes of the Toad Rhinella alata (Anura, Bufonidae). Molecules. https://doi.org/10.3390/molecules29010196
Vancouver
Rodriguez C, Ibáñez R, Olmedo DA, Ng M, Spadafora C, Durant-Archibold AA, et al. Anti-Trypanosomal Bufadienolides from the Oocytes of the Toad Rhinella alata (Anura, Bufonidae). Molecules. 2023. doi:10.3390/molecules29010196
BibTeX
@article{Rodriguez2023,
author = {Rodriguez, Candelario and Ibáñez, Roberto and Olmedo, Dionisio A and Ng, Michelle and Spadafora, Carmenza and Durant-Archibold, Armando A and Gutiérrez, Marcelino},
title = {Anti-Trypanosomal Bufadienolides from the Oocytes of the Toad Rhinella alata (Anura, Bufonidae)},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules29010196}
}
EUVIMED